Leit í EES-gagnagrunni
Commission Implementing Regulation (EU) …/... of XXX amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances dodemorph, fatty acids C8-C10 methyl esters, lauric acid, methyl octanoate, methyl decanoate, oleic acid and Trichoderma atroviride (formerly T. harzianum) strain IMI 206040
Commission Implementing Regulation (EU) …/... of XXX concerning the non-renewal of the approval of the active substance dimethomorph, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Commission Implementing Regulation (EU) …/... of XXX amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, dithianon, dodine, fluometuron, hexythiazox, isoxaben, lime sulphur, orange oil, prosulfuron, quinmerac, sintofen, sodium silver thiosulfate, tau fluvalinate, tebufenozide, tembotrione and zinc phosphide
Commission Implementing Regulation (EU) …/... of XXX concerning the non-renewal of the approval of the active substance mepanipyrim, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Commission Delegated Regulation (EU) …/... amending Regulation (EU) 2019/1021 of the European Parliament and of the Council as regards hexabromocyclododecane
Commission Delegated Regulation (EU) …/... amending Regulation (EU) No 528/2012 of the European Parliament and of the Council as regards a further extension of the duration of the work programme for the systematic examination of all existing biocidal active substances
Commission Regulation (EU) 2024/848 of 14 March 2024 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2024
Commission Regulation (EU) …/… of XXX amending Regulation (EC) No 440/2008 as regards the test methods, to adapt them to technical progress
Commission Delegated Directive (EU) .../… amending Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for cadmium in downshifting quantum dots directly deposited on LED semiconductor chips
Commission Delegated Directive (EU) .../… amending Directive 2010/63/EU of the European Parliament and of the Council as regards the requirements for establishments and for the care and accommodation of animals, and as regards the methods of killing animals
Commission Delegated Regulation (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use
Commission Regulation (EU) …/… of XXX amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards undecafluorohexanoic acid (PFHxA), its salts and PFHxA-related substances
D095068/01
Commission Implementing Decision (EU) 2024/888 of 22 March 2024 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2024/772 of 4 March 2024 granting a Union authorisation for the single biocidal product AEROCLEAN in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Delegated Regulation (EU) …/... amending Regulation (EU) No 528/2012 of the European Parliament and of the Council to include nitrogen generated from ambient air as an active substance in Annex I thereto
Commission Delegated Regulation (EU) …/... amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of the drug precursor Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM) and other substances in the list of scheduled substances
D095075/01
Commission Implementing Regulation (EU) 2024/878 of 21 March 2024 adopting uniform rules on the size of small immediate packaging units of veterinary medicinal products as referred to in Article 12 of Regulation (EU) 2019/6 of the European Parliament and of the Council
D095073/01
Commission Implementing Regulation (EU) 2024/860 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the substance 17β-oestradiol
D095074/01
Commission Implementing Regulation (EU) 2024/875 of 21 March 2024 adopting a list of abbreviations and pictograms common throughout the Union to be used on the packaging of veterinary medicinal products for the purposes of Article 10(2) and Article 11(3) of Regulation (EU) 2019/6 of the European Parliament and of the Council
D095325/01
Commission Implementing Regulation (EU) 2024/916 of 26 March 2024 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
D093445/02
Commission Implementing Regulation (EU) 2024/859 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
Commission Implementing Regulation (EU) …/... of XXX granting a Union authorisation for the biocidal product family ‘Kersia's Lactic acid based products’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094609/02
Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094047/03
Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094303/03
Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011